SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $60.86 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-03-15
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-12-31 was $15.85K, a 11.54% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-12-31 was $14.21K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $60.86K, a 11.43% increase from fiscal 2021.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $54.62K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|
| 2022-12-31 | $15.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $60.86K 10-K · filed 2023-03-15 | |
| 2022-09-30 | $45.01K 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $14.21K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $54.62K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $40.41K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |